Targeting INflammation Using SALsalate in Type 2 Diabetes (TINSAL-T2D)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Allison B. Goldfine, MD
Joslin Diabetes Center
Study Director - Kathleen Jablonski, PhD
George Washington University
Study Director - Myrlene Staten, MD
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Study Director - Steven E. Sheolson, MD, PhD
Joslin Diabetes Center
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
16 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Chapel Medical Group
New Haven, Connecticut, United States
- Medstar Research Institute
Washington D.C., District of Columbia, United States
- Endocrine Clinical Research
Winter Park, Florida, United States
- Emory School of Medicine
Atlanta, Georgia, United States
- Kaiser Permanente
Atlanta, Georgia, United States
- University of Illinois at Chicago
Chicago, Illinois, United States
- Tulane University
New Orleans, Louisiana, United States
- Joslin Diabetes Center
Boston, Massachusetts, United States
- Washington University School of Medicine
St Louis, Missouri, United States
- University of Nebraska Medical Center
Omaha, Nebraska, United States
- Kaleida Health Center
Buffalo, New York, United States
- North Shore Diabetes and Endocrine Associates
New Hyde Park, New York, United States
- Columbia University
New York, New York, United States
- University of Rochester Medical Center
Rochester, New York, United States
- University of North Carolina
Chapel Hill, North Carolina, United States
- University of Texas Southwestern
Dallas, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Oct 2006
- Primary completion
- 31 Jul 2008
- Completion
- 31 Dec 2010
- Last update posted
- 8 Apr 2019
- Registered enrollment
- 277
- Registry id
- NCT00392678
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.